304449-84-1Relevant articles and documents
In vivo targeting of tumor-associated carbonic anhydrases using acetazolamide derivatives
Ahlskog, Julia K.J.,Dumelin, Christoph E.,Truessel, Sabrina,Marlind, Jessica,Neri, Dario
, p. 4851 - 4856 (2009)
We describe the synthesis and characterization of two acetazolamide derivatives containing either a charged fluorophore or an albumin-binding moiety, which restrict binding to carbonic anhydrase IX and XII present on tumor cells. In vivo studies showed th
Synthesis and evaluation of tripodal peptide analogues for cellular delivery of phosphopeptides
Ye, Guofeng,Nam, Nguyen-Hai,Kumar, Anil,Saleh, Ali,Shenoy, Dinesh B.,Amiji, Mansoor M.,Lin, Xiaofeng,Sun, Gongqin,Parang, Keykavous
, p. 3604 - 3617 (2007)
Tripodal peptide analogues were designed on the basis of the phosphotyrosine binding pocket of the Src SH2 domain and assayed for their ability to bind to fluorescein-labeled phosphopeptides. Fluorescence polarization assays showed that a number of amphip
COMPOUND
-
Paragraph 0105; 0106, (2013/06/28)
In one aspect, there is provided a fluorescent iron-binding compound bound to a solid phase. Also provided is a method for detecting non-transferrin bound iron in a sample, comprising contacting the sample with a fluorescent iron-binding compound bound to a solid phase and detecting a fluorescent signal derived from the fluorescent iron-binding compound bound to the solid phase, wherein the fluorescent signal is indicative of non-transferrin bound iron levels in the sample. Further provided is use of a fluorescent iron-binding compound bound to a solid phase to detect non-transferrin bound iron in a sample.